Quantitative but not qualitative flavor recognition impairments in COVID-19 patients.


Journal

Irish journal of medical science
ISSN: 1863-4362
Titre abrégé: Ir J Med Sci
Pays: Ireland
ID NLM: 7806864

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 19 07 2021
accepted: 12 09 2021
pubmed: 26 9 2021
medline: 27 7 2022
entrez: 25 9 2021
Statut: ppublish

Résumé

Smell and taste dysfunctions (STDs) are symptoms associated with COVID-19 syndrome, even if their incidence is still uncertain and variable. In this study, the effects of SARS-CoV-2 infection on chemosensory function have been investigated using both a self-reporting questionnaire on smell and flavor perception, and a simplified flavor test. A total of 111 subjects (19 hospitalized [HOS] and 37 home-isolated [HI] COVID-19 patients, and 55 healthy controls [CTRL]) were enrolled in the study. They received a self-evaluation questionnaire and a self-administered flavor test kit. The flavor test used consists in the self-administration of four solutions with a pure olfactory stimulus (coffee), a mixed olfactory-trigeminal stimulus (peppermint), and a complex chemical mixture (banana). After SARS-CoV-2 infection, HOS and HI patients reported similar prevalence of STDs, with a significant reduction of both smell and flavor self-estimated perception. The aromas of the flavor test were recognized by HI and HOS COVID-19 patients similarly to CTRL; however, the intensity of the perceived aromas was significantly lower in patients compared to controls. Data reported here suggests that a chemosensory impairment is present after SARS-CoV-2 infection, and the modified "flavor test" could be a novel self-administering objective screening test to assess STDs in COVID-19 patients. NCT04840966; April 12, 2021, retrospectively registered.

Sections du résumé

BACKGROUND BACKGROUND
Smell and taste dysfunctions (STDs) are symptoms associated with COVID-19 syndrome, even if their incidence is still uncertain and variable.
AIMS OBJECTIVE
In this study, the effects of SARS-CoV-2 infection on chemosensory function have been investigated using both a self-reporting questionnaire on smell and flavor perception, and a simplified flavor test.
METHODS METHODS
A total of 111 subjects (19 hospitalized [HOS] and 37 home-isolated [HI] COVID-19 patients, and 55 healthy controls [CTRL]) were enrolled in the study. They received a self-evaluation questionnaire and a self-administered flavor test kit. The flavor test used consists in the self-administration of four solutions with a pure olfactory stimulus (coffee), a mixed olfactory-trigeminal stimulus (peppermint), and a complex chemical mixture (banana).
RESULTS RESULTS
After SARS-CoV-2 infection, HOS and HI patients reported similar prevalence of STDs, with a significant reduction of both smell and flavor self-estimated perception. The aromas of the flavor test were recognized by HI and HOS COVID-19 patients similarly to CTRL; however, the intensity of the perceived aromas was significantly lower in patients compared to controls.
CONCLUSION CONCLUSIONS
Data reported here suggests that a chemosensory impairment is present after SARS-CoV-2 infection, and the modified "flavor test" could be a novel self-administering objective screening test to assess STDs in COVID-19 patients.
CLINICAL TRIAL REGISTRATION NO BACKGROUND
NCT04840966; April 12, 2021, retrospectively registered.

Identifiants

pubmed: 34562193
doi: 10.1007/s11845-021-02786-x
pii: 10.1007/s11845-021-02786-x
pmc: PMC8475319
doi:

Banques de données

ClinicalTrials.gov
['NCT04840966']

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1759-1766

Informations de copyright

© 2021. The Author(s).

Références

Cantone E, Gamerra M (2020) The biometeorology of COVID-19: a novel therapeutic strategy? Acta Medica (Hradec Kralove) 63 (4):202-204. https://doi.org/10.14712/18059694.2020.65
Richardson S, Hirsch JS, Narasimhan M (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323(20):2052–2059. https://doi.org/10.1001/jama.2020.6775
doi: 10.1001/jama.2020.6775 pubmed: 32320003 pmcid: 7177629
Welge-Lussen A, Wolfensberger M (2006) Olfactory disorders following upper respiratory tract infections. Advances in oto-rhino-laryngology 63:125–132. https://doi.org/10.1159/000093758
doi: 10.1159/000093758 pubmed: 16733337
Gerkin RC, Ohla K, Veldhuizen MG et al (2020) Recent smell loss is the best predictor of COVID-19: a preregistered, cross-sectional study. medRxiv. https://doi.org/10.1101/2020.07.22.20157263
Yan CH, Faraji F, Prajapati DP et al (2020) Self-reported olfactory loss associates with outpatient clinical course in COVID-19. International forum of allergy & rhinology 10(7):821–831. https://doi.org/10.1002/alr.22592
doi: 10.1002/alr.22592
Hopkins C, Vaira LA, De Riu G (2020) Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor? International forum of allergy & rhinology 10(7):926. https://doi.org/10.1002/alr.22608
doi: 10.1002/alr.22608
Sociedad.Espanola.de.Neurologia. https://www.sen.es/noticias-y-actividades/222-noticias/covid-19-informacion-para-pacientes/2663-covid-recomendaciones-de-la-sociedad-espanola-de-neurologia-sen-en-relacion-con-la-perdida-de-olfato-como-posible-sintoma-precoz-de-infeccion-por-covid-19 .
Paderno A, Schreiber A, Grammatica A et al (2020) Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts. International forum of allergy & rhinology 10(8):955–962. https://doi.org/10.1002/alr.22610
doi: 10.1002/alr.22610
Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181 (2):271-280 e278. https://doi.org/10.1016/j.cell.2020.02.052
Perrotta F, Matera MG, Cazzola M, Bianco A (2020) Severe respiratory SARS-CoV2 infection: does ACE2 receptor matter? Respir Med 168:105996. https://doi.org/10.1016/j.rmed.2020.105996
doi: 10.1016/j.rmed.2020.105996 pubmed: 32364961 pmcid: 7194970
Gamerra M, de Corso E, Cantone E (2021) COVID-19: the crucial role of the nose. Braz J Otorhinolaryngol 87(1):118–119. https://doi.org/10.1016/j.bjorl.2020.08.001
doi: 10.1016/j.bjorl.2020.08.001 pubmed: 33008766
Guedj E, Million M, Dudouet P et al (2021) (18)F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging 48(2):592–595. https://doi.org/10.1007/s00259-020-04973-x
doi: 10.1007/s00259-020-04973-x pubmed: 32728799
Marchese-Ragona R, Restivo DA, De Corso E et al (2020) Loss of smell in COVID-19 patients: a critical review with emphasis on the use of olfactory tests. Acta Otorhinolaryngol Ital 40 (4):241-247. https://doi.org/10.14639/0392-100X-N0862
Lima MA, Silva MTT, Oliveira RV et al (2020) Smell dysfunction in COVID-19 patients: more than a yes-no question. J Neurol Sci 418:117107. https://doi.org/10.1016/j.jns.2020.117107
doi: 10.1016/j.jns.2020.117107 pubmed: 32866813 pmcid: 7449134
Moein ST, Hashemian SMR, Mansourafshar B et al (2020) Smell dysfunction: a biomarker for COVID-19. International forum of allergy & rhinology. https://doi.org/10.1002/alr.22587
doi: 10.1002/alr.22587
Lechner M, Patel ZM, Philpott C, Lund VJ (2020) Olfactory loss of function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. https://doi.org/10.1001/jamaoto.2020.1589
doi: 10.1001/jamaoto.2020.1589 pubmed: 32672804
Brookes NRG, Fairley JW, Brookes GB (2020) Acute olfactory dysfunction—a primary presentation of COVID-19 infection. Ear Nose Throat J:145561320940119. https://doi.org/10.1177/0145561320940119
Moein ST, Hashemian SM, Tabarsi P, Doty RL (2020) Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients. International forum of allergy & rhinology. https://doi.org/10.1002/alr.22680
doi: 10.1002/alr.22680
Bagnasco D, Passalacqua G, Braido F et al (2021) Quick Olfactory Sniffin’ Sticks Test (Q-Sticks) for the detection of smell disorders in COVID-19 patients. World Allergy Organ J 14(1):100497. https://doi.org/10.1016/j.waojou.2020.100497
doi: 10.1016/j.waojou.2020.100497 pubmed: 33495704 pmcid: 7816565
Mazzoli M, Molinari MA, Tondelli M et al (2021) Olfactory function and viral recovery in COVID-19. Brain Behav:e02006. https://doi.org/10.1002/brb3.2006
Lechien JR, Journe F, Hans S et al (2020) Severity of anosmia as an early symptom of COVID-19 infection may predict lasting loss of smell. Front Med (Lausanne) 7:582802. https://doi.org/10.3389/fmed.2020.582802
doi: 10.3389/fmed.2020.582802
Lechien JR, Chiesa-Estomba CM, De Siati DR et al (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 277(8):2251–2261. https://doi.org/10.1007/s00405-020-05965-1
doi: 10.1007/s00405-020-05965-1 pubmed: 32253535 pmcid: 7134551
Burdach KJ, Doty RL (1987) The effects of mouth movements, swallowing, and spitting on retronasal odor perception. Physiol Behav 41(4):353–356
doi: 10.1016/0031-9384(87)90400-8
Small DM, Voss J, Mak YE et al (2004) Experience-dependent neural integration of taste and smell in the human brain. J Neurophysiol 92(3):1892–1903. https://doi.org/10.1152/jn.00050.2004
doi: 10.1152/jn.00050.2004 pubmed: 15102894
Blankenship ML, Grigorova M, Katz DB, Maier JX (2019) Retronasal odor perception requires taste cortex, but orthonasal does not. Curr Biol 29 (1):62-69 e63. https://doi.org/10.1016/j.cub.2018.11.011
Espinosa Diaz M (2004) Comparison between orthonasal and retronasal flavour perception at different concentrations. Flavour Fragr J 19:499–504
doi: 10.1002/ffj.1475
Goldberg EM, Wang K, Goldberg J, Aliani M (2018) Factors affecting the ortho- and retronasal perception of flavors: a review. Crit Rev Food Sci Nutr 58(6):913–923. https://doi.org/10.1080/10408398.2016.1231167
doi: 10.1080/10408398.2016.1231167 pubmed: 27646486
Chaaban N, Hoier A, Andersen BV (2021) A detailed characterisation of appetite, sensory perceptional, and eating-behavioural effects of COVID-19: self-reports from the acute and post-acute phase of disease. Foods 10 (4). 10.3390/foods10040892
Maione L, Cantone E, Nettore IC et al (2016) Flavor perception test: evaluation in patients with Kallmann syndrome. Endocrine 52(2):236–243. https://doi.org/10.1007/s12020-015-0690-y
doi: 10.1007/s12020-015-0690-y pubmed: 26209039
Nettore IC, Maione L, Desiderio S et al (2020) Influences of age, sex and smoking habit on flavor recognition in healthy population. International journal of environmental research and public health 17 (3). https://doi.org/10.3390/ijerph17030959
Nettore IC, Maione L, Palatucci G et al (2020) Flavor identification inversely correlates with body mass index (BMI). Nutrition, metabolism, and cardiovascular diseases : NMCD. https://doi.org/10.1016/j.numecd.2020.04.005
doi: 10.1016/j.numecd.2020.04.005 pubmed: 32513578
De Rosa A, Nettore IC, Cantone E et al (2019) The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson’s disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 40(7):1351–1356. https://doi.org/10.1007/s10072-019-03842-2
doi: 10.1007/s10072-019-03842-2
Sollai G, Tomassini Barbarossa I, Usai P, Hummel T et al (2020) Association between human olfactory performance and ability to detect single compounds in complex chemical mixtures. Physiol Behav 217:112820. https://doi.org/10.1016/j.physbeh.2020.112820
doi: 10.1016/j.physbeh.2020.112820 pubmed: 31987895
Mehraeen E, Behnezhad F, Salehi MA et al (2020) Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-06120-6
doi: 10.1007/s00405-020-06120-6 pubmed: 32556781 pmcid: 7297932
Walker A, Pottinger G, Scott A, Hopkins C (2020) Anosmia and loss of smell in the era of COVID-19. BMJ 370:m2808. https://doi.org/10.1136/bmj.m2808
doi: 10.1136/bmj.m2808 pubmed: 32694187
Niklassen AS, Draf J, Huart C et al (2021) COVID-19: recovery from chemosensory dysfunction. A multicentre study on smell and taste. Laryngoscope. https://doi.org/10.1002/lary.29383
Gerkin RC, Ohla K, Veldhuizen MG et al (2021) Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms Chemical senses 46.  https://doi.org/10.1093/chemse/bjaa081
Romer M, Lehrner J, Van Wymelbeke V et al (2006) Does modification of olfacto-gustatory stimulation diminish sensory-specific satiety in humans? Physiol Behav 87(3):469–477. https://doi.org/10.1016/j.physbeh.2005.11.015
doi: 10.1016/j.physbeh.2005.11.015 pubmed: 16458336
Leijon SCM, Neves AF, Breza JM et al (2019) Oral thermosensing by murine trigeminal neurons: modulation by capsaicin, menthol and mustard oil. J Physiol 597(7):2045–2061. https://doi.org/10.1113/JP277385
doi: 10.1113/JP277385 pubmed: 30656684 pmcid: 6441899
Pal P, Shepherd D, Hamid N, Hautus MJ (2019) The use of freeze-dried retronasal stimuli to assess olfactory function. Clin Otolaryngol 44(5):770–777. https://doi.org/10.1111/coa.13389
doi: 10.1111/coa.13389 pubmed: 31199078
Iravani B, Arshamian A, Ravia A et al (2020) Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population. Chem Senses. https://doi.org/10.1093/chemse/bjaa034
doi: 10.1093/chemse/bjaa034 pubmed: 32441744
Konstantinidis I, Delides A, Tsakiropoulou E et al (2020) Short-term follow-up of self-isolated COVID-19 patients with smell and taste dysfunction in Greece: two phenotypes of recovery. ORL J Otorhinolaryngol Relat Spec 82(6):295–303. https://doi.org/10.1159/000511436
doi: 10.1159/000511436 pubmed: 33049753
Huart C, Philpott C, Konstantinidis I et al (2020) Comparison of COVID-19 and common cold chemosensory dysfunction. Rhinology. https://doi.org/10.4193/Rhin20.251
doi: 10.4193/Rhin20.251 pubmed: 32830809
Klopfenstein T, Zahra H, Kadiane-Oussou NJ et al (2020) New loss of smell and taste: uncommon symptoms in COVID-19 patients in Nord Franche-Comte cluster, France. Int J Infect Dis 100:117–122. https://doi.org/10.1016/j.ijid.2020.08.012
doi: 10.1016/j.ijid.2020.08.012 pubmed: 32771635 pmcid: 7410813
Saussez S, Lechien JR, Hopkins C (2020) Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-06285-0
doi: 10.1007/s00405-020-06285-0 pubmed: 32909060 pmcid: 7480210
Hoffman HJ, Rawal S, Li CM, Duffy VB (2016) New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction. Rev Endocr Metab Disord 17 (2):221-240. https://doi.org/10.1007/s11154-016-9364-1
Pinna FdR, Brandão Neto D, Fornazieri MA, Voegels RL (2020) Olfaction and COVID: the little we know and what else we need to know. Int Arch Otorhinolaryngol (EFirst). https://doi.org/10.1055/s-0040-1713143
Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T (2020) The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 163(1):3–11. https://doi.org/10.1177/0194599820926473
doi: 10.1177/0194599820926473 pubmed: 32369429
Fantozzi PJ, Pampena E, Di Vanna D et al (2020) Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19. Am J Otolaryngol 41(6):102721. https://doi.org/10.1016/j.amjoto.2020.102721
doi: 10.1016/j.amjoto.2020.102721 pubmed: 32977063 pmcid: 7482593
Mullol J, Alobid I, Marino-Sanchez F et al (2020) The loss of smell and taste in the COVID-19 outbreak: a tale of many countries. Curr Allergy Asthma Rep 20(10):61. https://doi.org/10.1007/s11882-020-00961-1
doi: 10.1007/s11882-020-00961-1 pubmed: 32748211 pmcid: 7397453
Du RH, Liang LR, Yang CQ et al (2020) Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J 55 (5). https://doi.org/10.1183/13993003.00524-2020
Polidori MC, Sies H, Ferrucci L, Benzing T (2021) COVID-19 mortality as a fingerprint of biological age. Ageing Res Rev 67:101308. https://doi.org/10.1016/j.arr.2021.101308
doi: 10.1016/j.arr.2021.101308 pubmed: 33621704 pmcid: 7896489
Wenham C, Smith J, Morgan R, Gender, Group C-W (2020) COVID-19: the gendered impacts of the outbreak. Lancet 395(10227):846–848. https://doi.org/10.1016/S0140-6736(20)30526-2
doi: 10.1016/S0140-6736(20)30526-2

Auteurs

Immacolata Cristina Nettore (IC)

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.

Elena Cantone (E)

Dipartimento di Neuroscienze e Scienze della Riproduzione e Odontostomatologiche, Università degli Studi di Napoli Federico II, Napoli, Italy.

Giuseppe Palatucci (G)

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.

Fabiana Franchini (F)

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.

Rufina Maturi (R)

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.

Mariagiovanna Nerilli (M)

Ospedale dei Colli, Napoli, Italy.

Elio Manzillo (E)

Ospedale dei Colli, Napoli, Italy.

Maria Foggia (M)

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.

Luigi Maione (L)

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.

Paola Ungaro (P)

Istituto per l'Endocrinologia ed Oncologia Sperimentale (IEOS) G. Salvatore, CNR, Nazionale per le Ricerche, Napoli, Consiglio, Italy.

Annamaria Colao (A)

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.

Paolo Emidio Macchia (PE)

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy. pmacchia@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH